首页> 美国卫生研究院文献>Diagnostics >Diagnostic and Therapeutic Applications of Extracellular Vesicles in Interstitial Lung Diseases
【2h】

Diagnostic and Therapeutic Applications of Extracellular Vesicles in Interstitial Lung Diseases

机译:细胞外囊泡在间质肺病中的诊断和治疗应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Interstitial lung diseases (ILDs) are chronic irreversible pulmonary conditions with significant morbidity and mortality. Diagnostic approaches to ILDs are complex and multifactorial. Effective therapeutic interventions are continuously investigated and explored with substantial progress, thanks to advances in basic understanding and translational efforts. Extracellular vesicles (EVs) offer a new paradigm in diagnosis and treatment. This leads to two significant implications: new disease biomarker discovery that enables reliable diagnosis and disease assessment and the development of regenerative medicine therapeutics that target fibroproliferative processes in diseased lung tissue. In this review, we discuss the current understanding of the role of diseased tissue-derived EVs in the development of interstitial lung diseases, the utility of these EVs as diagnostic and prognostic tools, and the existing therapeutic utility of EVs. Furthermore, we review the potential therapeutic application of EVs derived from various cellular sources.
机译:间质肺病(ILD)是慢性不可逆的肺部条件,具有显着的发病率和死亡率。 ILDS的诊断方法是复杂和多因素。由于基本理解和翻译努力,不断调查和探索有效的治疗干预措施,并探讨了实质性进展。细胞外囊泡(EVS)在诊断和治疗中提供了一种新的范式。这导致了两个显着影响:新疾病生物标志物发现,可实现可靠的诊断和疾病评估以及再生医学治疗的开发,靶向患有肺组织中的纤维增育过程。在这篇综述中,我们讨论目前对患病组织衍生EV在间质肺病发育中的作用的理解,这些EVS作为诊断和预后工具的效用以及EVS的现有治疗效用。此外,我们审查了来自各种细胞来源的EVS的潜在治疗应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号